Norge - norsk - Statens legemiddelverk

cis bio international - butedronatetetranatrium - preparasjonssett til radioaktive legemidler - 13 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

genzyme europe b.v. - alemtuzumab - leukemi, lymfocytisk, kronisk, b-celle - antineoplastiske midler - mabcampath er indisert for behandling av pasienter med b-celle kronisk lymfocytisk leukemi (bcll) for hvem fludarabinkombinasjon kjemoterapi ikke er hensiktsmessig.

Norge - norsk - Statens legemiddelverk

cis bio international - natriumjodid (131 i) - kapsel, hard - 50 mbq

Norge - norsk - Statens legemiddelverk

ge healthcare as - albumin humant kolloidale partikler ad tc-99m albumin nanokolloid - pulver til injeksjonsvæske, suspensjon

Norge - norsk - Statens legemiddelverk

curium netherlands b.v. - natriumjodid (131i) - kapsel, hard

Den europeiske union - norsk - EMA (European Medicines Agency)

instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.